ARCHIVES

BRCA1 and BRCA2 Mutations Linked To Higher Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says

February 13, 1998

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

In Brief: Wittes To Become Acting DCT Director; Kaufman Leaves NCI For Private Practice

February 17, 1995

In Brief: Minna to Leave NCI For Texas Southwestern; Alexander Is Special Populations Branch Chief

February 22, 1991

Funding Opportunities.

April 11, 2003

Survey Shows That One-Third Of Patients Are Undertreated

April 27, 2012